EPSTEIN-BARR virus pneumonitis in a immunocompetent young adult.

Computed tomography scan EBV Lung Pneumonia

Journal

Respiratory medicine case reports
ISSN: 2213-0071
Titre abrégé: Respir Med Case Rep
Pays: England
ID NLM: 101604463

Informations de publication

Date de publication:
2024
Historique:
received: 22 12 2023
revised: 22 03 2024
accepted: 20 06 2024
medline: 22 7 2024
pubmed: 22 7 2024
entrez: 22 7 2024
Statut: epublish

Résumé

Epstein-Barr virus (EBV) is a common human Herpesvirus with worldwide distribution. Primary EBV infection usually occurs early in life and typically presents as infectious mononucleosis consisting of fever, pharyngitis, hepatosplenomegaly, and lymphadenopathy. Usually, the disease course is benign and most patients recover uneventfully without any consequent sequel. We present a case of an immunologically normal young male in whom an acute EBV infection caused severe pneumonitis. He was treated empirically with Paracetamol, intravenous Ceftriaxone 1 gr/day plus Azithromycin 500 mg/day. EBV-associated pneumonitis is rare, and treatment is usually supportive, whether antiviral agents (such as acyclovir) or steroids would be beneficial remains to be determined.

Sections du résumé

Background UNASSIGNED
Epstein-Barr virus (EBV) is a common human Herpesvirus with worldwide distribution. Primary EBV infection usually occurs early in life and typically presents as infectious mononucleosis consisting of fever, pharyngitis, hepatosplenomegaly, and lymphadenopathy. Usually, the disease course is benign and most patients recover uneventfully without any consequent sequel.
Method and results UNASSIGNED
We present a case of an immunologically normal young male in whom an acute EBV infection caused severe pneumonitis. He was treated empirically with Paracetamol, intravenous Ceftriaxone 1 gr/day plus Azithromycin 500 mg/day.
Conclusion UNASSIGNED
EBV-associated pneumonitis is rare, and treatment is usually supportive, whether antiviral agents (such as acyclovir) or steroids would be beneficial remains to be determined.

Identifiants

pubmed: 39035789
doi: 10.1016/j.rmcr.2024.102080
pii: S2213-0071(24)00103-5
pmc: PMC11260324
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

102080

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

No conflict.

Auteurs

Jawad Hindy (J)

Department of Gastroenterology and Liver Disease, Bnai Zion Medical Center, Haifa, Israel.
The Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.

Tova Rainis (T)

Department of Gastroenterology and Liver Disease, Bnai Zion Medical Center, Haifa, Israel.
The Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.

Classifications MeSH